therapeutic radiopharmaceuticals in prostate cancer: what the urologist needs to know
Published 2 months ago • 188 plays • Length 7:29Download video MP4
Download video MP3
Similar videos
-
15:52
therapeutic radiopharmaceuticals and the emergence of theranostics in prostate cancer
-
20:48
mri in the enhanced detection of prostate cancer: what urologists need to know
-
16:49
theranostics in prostate cancer
-
14:39
just the beginning: what's next for radiotheranostics in prostate cancer?
-
25:25
nutrition and prostate cancer what we think we know and what we actually know
-
16:52
mri in the management of prostate cancer
-
35:48
adt is the building block for advanced prostate cancer therapy
-
40:09
adt as foundational therapy
-
10:51
advanced prostate cancer clinical trials update 2022
-
9:27
patient selection for prostate cancer focal therapy: urologic perspective
-
24:32
when to use hormone therapy with radiation therapy
-
0:48
what does the future hold for radiopharmaceuticals in prostate cancer?
-
10:09
psma targeted therapies and the role of the urologist
-
10:38
updates in treatment using adt and anti-androgens
-
54:36
uw urology grand rounds "the evolving management of high risk prostate cancer" - 9/6/2023
-
14:18
prostate inflammation and prostate cancer: what do i need to know?
-
21:18
rationale for focal therapy for prostate cancer
-
26:54
fluciclovine (18f) pet/ct impact on clinical management of recurrent prostate cancer
-
16:28
appropriate use of psma pet in clinical practice